Pirfenidone

CAS 53179-13-8 31 current records 1 historicalSmall Molecule

Who holds supplier records for Pirfenidone? 31 organisations hold a current record for Pirfenidone: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 24 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (23), Italy (3), United Kingdom (1) and Spain (1); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Pirfenidone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pirfenidone

Reading the evidence

  • 31 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    23 of the 28 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 17 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Pirfenidone expires 28 Mar 2037. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (31)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Pirfenidone. Country is the organisation's recorded country, not necessarily the manufacturing site.

India23Italy3United Kingdom1Spain1Country not recorded for 3
Need Pirfenidone sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (24)

Certificates of Suitability on the EDQM register for Pirfenidone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 28 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
CHEMO IBERICA S.A. MadridES
CEP 2026-434 - Rev 00
Pirfenidone, MAHI Drugs site
Nov 2026—
PROCOS S.P.A. CameriIT
CEP 2020-073 - Rev 01
Pirfenidone
Oct 2026Inspected Oct 2025
Italy
DIPHARMA FRANCIS S.R.L. BaranzateIT
CEP 2024-493 - Rev 00
Pirfenidone
Sept 2026Inspected Mar 2025
Italy
CAMBREX PROFARMACO MILANO S.R.L. PaulloIT
CEP 2019-248 - Rev 01
Pirfenidone
Sept 2026Inspected Sept 2025
Italy
HONOUR LAB LIMITED HyderabadIN
CEP 2016-122 - Rev 01
Pirfenidone
Aug 2026—
GRANULES INDIA LIMITED HyderabadIN
CEP 2016-288 - Rev 03
Pirfenidone, Crystalline Form
May 2026—
ALIVUS LIFE SCIENCES LIMITED MumbaiIN
CEP 2017-170 - Rev 05
Pirfenidone
May 2026—
SMS PHARMACEUTICALS LIMITED HyderabadIN
CEP 2024-559 - Rev 00
Pirfenidone
Apr 2026—
JUBILANT BIOSYS LIMITED MysuruIN
CEP 2018-091 - Rev 04
Pirfenidone
Jan 2026—
CIPLA LIMITED MumbaiIN
CEP 2018-096 - Rev 01
Pirfenidone
Oct 2025—
MICRO LABS LIMITED BengaluruIN
CEP 2019-155 - Rev 02
Pirfenidone
Jun 2025—
ROLABO OUTSOURCING, S.L. ZaragozaES
CEP 2018-260 - Rev 01
Pirfenidone
May 2025Inspected Dec 2023
Spain
LAURUS LABS LIMITED HyderabadIN
CEP 2019-062 - Rev 02
Pirfenidone
May 2025—
OPTIMUS DRUGS PRIVATE LIMITED HyderabadIN
CEP 2018-007 - Rev 02
Pirfenidone
May 2025—
SNJ LABS PRIVATE LIMITED Dist. RajkotIN
CEP 2024-165 - Rev 00
Pirfenidone
May 2025—
AMOLI ORGANICS PRIVATE LIMITED MumbaiIN
CEP 2019-067 - Rev 02
Pirfenidone
Apr 2025—
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
CEP 2016-242 - Rev 01
Pirfenidone, micronised, non-micronised
Apr 2025—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
CEP 2018-147 - Rev 02
Pirfenidone
Feb 2025—
LUPIN MANUFACTURING SOLUTIONS LIMITED MumbaiIN
CEP 2017-109 - Rev 04
Pirfenidone
Oct 2024—
COHANCE LIFESCIENCES LIMITED MumbaiIN
CEP 2017-259 - Rev 03
Pirfenidone
Jul 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2018-098 - Rev 03
Pirfenidone
Jun 2024—
MSN LIFE SCIENCES PRIVATE LIMITED Chandampet VillageIN
CEP 2017-103 - Rev 02
Pirfenidone, Crystalline form
Mar 2024Inspected Oct 2025
Slovakia
SHIVALIK RASAYAN LIMITED New DelhiIN
CEP 2021-413 - Rev 00
Pirfenidone
Jan 2024—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
R0-CEP 2021-077 - Rev 00
Pirfenidone
Jun 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Pirfenidone are no longer active. These show a past filing, not current supply.

Show all 1 historical record

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (37 listed products contain Pirfenidone). The latest listed patent expires 28 Mar 2037. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Pirfenidone is a pyridine derivative with antifibrotic properties used to treat idiopathic pulmonary fibrosis by reducing lung fibrosis through modulation of the cytokine cascade. It is believed to exert its therapeutic effects by inhibiting TGF-beta and collagen synthesis and decreasing fibroblast proliferation.

Chemical identity

IUPAC name
5-methyl-1-phenylpyridin-2-one
Canonical SMILES
CC1=CN(C(=O)C=C1)C2=CC=CC=C2
InChIKey
ISWRGOKTTBVCFA-UHFFFAOYSA-N
Synonyms
Esbriet API, amr-69, esbriet, esbriet component pirfenidone, nsc-748456, pirespa

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Pyridone
Chemical structure
Pyridones

Therapeutic areas

PulmonologyRespiratory Therapy

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Pirfenidone?

31 organisations hold an active US FDA Type II Drug Master File or a CEP for Pirfenidone: HONOUR LAB LTD (India), Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), Cipla Limited (India), COHANCE LIFESCIENCES LTD (India), Dipharma Francis Srl (Italy) and Granules India Limited (India), and 23 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Pirfenidone Drug Master Files are active?

HONOUR LAB LTD (DMF 40331, 29700), Alembic Pharmaceuticals Limited (DMF 32772), ALIVUS LIFE SCIENCES LTD (DMF 31072), APITORIA PHARMA PRIVATE LTD (DMF 32696), Cipla Limited (DMF 32423), COHANCE LIFESCIENCES LTD (DMF 32201), Dipharma Francis Srl (DMF 32224) and Granules India Limited (DMF 30922) and 18 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Pirfenidone records mean?

1 organisation has only inactive Type II DMFs for Pirfenidone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Pirfenidone have a European Certificate of Suitability?

Yes. 24 organisations hold a valid CEP for Pirfenidone on the EDQM register, including CHEMO IBERICA S.A. Madrid (ES), PROCOS S.P.A. Cameri (IT), DIPHARMA FRANCIS S.R.L. Baranzate (IT), CAMBREX PROFARMACO MILANO S.R.L. Paullo (IT), HONOUR LAB LIMITED Hyderabad (IN) and GRANULES INDIA LIMITED Hyderabad (IN) and 18 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Pirfenidone?

Yes. The latest patent listed for an approved US product containing Pirfenidone expires 28 Mar 2037, across 37 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Pirfenidone supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Pirfenidone?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.